Great news! Warm congratulations to TransEasy won the special new honorary title of “Little  Giant “ Firm.
Source: 天助畅运Date: 2023.07.14

On July 14, 2023, the Beijing Municipal Bureau of Economy and Information Technology announced the list of the fifth batch of specialized, special, and new "little giant" and TransEasy successfully passed the national certification of this title. 

01

Specialized, Refined, Characterized and Novelty "Small Giants" Enterprises (SRCN Small Giants).


It is a major project organized by the Ministry of Industry and Information Technology of the People's Republic of China to further implement the "Guiding Opinions on Promoting the Healthy Development of Small and Medium-sized Enterprises" issued by the Office of the Central Committee and the State Council, guide small and medium-sized enterprises to take the path of specialization, refinement, characterization, and novelty, enhances their independent innovation capabilities and core competitiveness and promote the transformation and upgrading of small and medium-sized enterprises and high-quality development.


According to the interim measures for the gradient cultivation and management of high--quality small and medium-sized enterprises issued by the Ministry of Industry and Information Technology, the identification of high-quality small and medium-sized enterprises are divided into three gradients of innovative small and medium-sized enterprises, specialized, special and new small and medium-sized enterprises, specialized, special, and new little giant firms, of which the identification standard of specialized, special, and new little giant enterprises are the highest.


The "little giant" is the leader in the "specialized, special and new" enterprises, and the enterprises selected in the list of the "little giant" enterprises need to reach the industry-leading level in terms of economic efficiency, innovation ability, operation and management, specialization, and other special conditions.


This time, TransEasy was identified as a ‘specialized special and new little giant’, which represents that the company has been fully recognized by the government and the industry in terms of independent innovation in key technologies, product performance and quality, refined operation and management, and market share of market segments.


02

Adhere to the development path of specialization, refinement, and innovation.


TransEasy Medical Tech. Co., Ltd. was founded in 2002, in Beijing. The company is mainly engaged in the R&D, production and sales of hernia repair products and other general surgical devices.


The company has 10,000+m2 R&D and production base, attaches great importance to scientific and technological innovation work, and has 91 authorized patents, including 4 international invention patents. In the field of hernia and abdominal wall surgery, the company has repeatedly obtained the first domestic product registration certificate, breaking the monopoly situation of imported enterprises, leading the development direction of the domestic hernia repair industry.


In addition to hernia and abdominal wall surgery products, the company continues to expand the development field, and has completed the product development layout in seven fields: access products, hemostasis products, stapler products, enhanced protection products, suture products, and occlusion products.


It is the unremitting efforts of all the employees of the company for years, with a professional R & D team, elaborate enterprise management, characteristics innovation ability and novel marketing strategies, so that the reputation of “the little giant” is deserved.


In the future, TransEasy will adhere to the development path of specialization, refinement, and novelization, continue to deepen the field of general surgery, constantly explore technological innovation, strengthen the company's independent innovation ability, enhance the company's core competitiveness, give full play to the industry's leading role, and strive to become a respected innovative national enterprise in the medical field.